The downgrade is based on several factors, including Bethesda’s multiple years of challenged operating performance.
The outlook is negative, reflecting Bethesda’s ongoing challenges regarding operating performance and operating leverage.
More articles on healthcare finance:
Following budget impasse, hospitals see delay in medical treatment, rise in cash payments
Under Medicare Part B changes, reimbursement tipping point at $480 a day per drug: 5 cost findings from Avalere
Meet the online medical billing and coding training company that already has 1 million views on YouTube
